Overview

Obeticholic acid (Obetix) 5 mg tablets act through a fundamentally different route from cytotoxic drugs: they activate the farnesoid X receptor, a nuclear receptor that regulates bile acid synthesis and transport. For buyers supporting hepatology programs, this FXR-agonist mechanism is the scientific core of the product and the reason it is used in primary biliary cholangitis. This guide explains the receptor-level action behind the clinical benefit.

How It Works

Obeticholic acid is a semisynthetic bile acid analog and potent agonist of the farnesoid X receptor expressed in liver and intestine. FXR activation suppresses CYP7A1, the rate-limiting enzyme in bile acid synthesis, and promotes efflux transporters that reduce intrahepatic bile acid accumulation. By lowering the toxic bile acid pool, the agent eases the cholestatic injury that drives primary biliary cholangitis progression. The mechanism is therefore a transcriptional reset of bile-acid homeostasis rather than direct cytotoxic tumor control. Clinicians track alkaline phosphatase and bilirubin to confirm the pathway has shifted toward a lower-burden bile-acid state.

Indications

Obeticholic acid is indicated for primary biliary cholangitis in adults who have inadequate response to ursodeoxycholic acid or cannot tolerate it, used alone or in combination. Response is monitored through alkaline phosphatase and bilirubin. Procurement should note the chronic, ongoing nature of therapy, which sustains steady reorder demand within hepatology channels. Because primary biliary cholangitis progresses slowly, the agent is typically continued for years, reinforcing the need for dependable, authenticated supply.

Dosage & Administration

The presentation is 5 mg film-coated tablets, 30 tablets per box. Therapy is initiated at a low dose with titration based on tolerability and liver-function markers, taken orally once daily. Tablets are swallowed whole. Buyers should confirm the 5 mg strength and expiry, because the starting and titrated doses differ and depend on accurate product identification. Working with accredited distributors simplifies reordering and reduces the risk of receiving mismatched strengths.

Storage & Sourcing

Store below 30 °C in the original packaging, protected from moisture and light. Obeticholic acid should be sourced from licensed manufacturers such as Everest, Tlph or Beacon with verifiable GMP documentation. Requesting certificates of analysis and batch traceability helps ensure authenticity for a chronic hepatology product with continuous demand.

FAQ

Q: What does activating the FXR receptor actually do? FXR activation turns down bile-acid synthesis via CYP7A1 suppression and boosts efflux, lowering the toxic intrahepatic bile-acid pool that drives cholestatic injury.

Q: Why is obeticholic acid used when ursodeoxycholic acid fails? It offers a distinct nuclear-receptor mechanism for patients with inadequate response or intolerance to UDCA in primary biliary cholangitis.

Q: What sourcing checks protect chronic supply? Require GMP certificates, analysis certificates and batch traceability from authorized manufacturers, and plan for ongoing reorders.